Related Experiment Video
Updated: Feb 6, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging
Kelly E Henry1, Gary A Ulaner2, Jason S Lewis3
1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Abstract:
Increased expression of the human epidermal growth factor receptor (HER) protein family are targets in breast cancer for imaging and therapy. Imaging modalities targeting HER2 and HER3 can diagnose breast cancer with a specific, biologically relevant target. Repeat biopsies do not address heterogeneity intratumorally or between primary disease and metastasis. HER2- and HER3-targeted PET is an important tool to diagnose disease in breast cancer and evaluate response to targeted therapies. PET and single photon emission computed tomography with radiolabeled biomolecules can be used to detect and quantify specific targets, conferring a better understanding of the behavior and effectiveness of treatments.
Insights
Positron emission tomography (PET) imaging targeting human epidermal growth factor receptors (HER2 and HER3) aids breast cancer diagnosis and treatment response evaluation. This approach addresses tumor heterogeneity, offering a more precise understanding of disease progression and therapeutic efficacy.
Area of Science:
- Oncology
- Radiology
- Molecular Imaging
Background:
- Human epidermal growth factor receptor (HER) family proteins are key targets in breast cancer therapy and imaging.
- Current diagnostic methods like repeat biopsies fail to capture tumor heterogeneity.
- Targeting HER2 and HER3 offers specific, biologically relevant diagnostic and therapeutic avenues.
Purpose of the Study:
- To highlight the utility of HER2- and HER3-targeted PET imaging in breast cancer.
- To emphasize the role of PET in diagnosing breast cancer and assessing treatment response.
- To underscore the importance of advanced imaging in understanding tumor behavior and treatment effectiveness.
Main Methods:
- Utilizing positron emission tomography (PET) with radiolabeled biomolecules targeting HER2 and HER3.
- Employing single photon emission computed tomography (SPECT) for target detection and quantification.
- Analyzing the diagnostic and therapeutic implications of targeted molecular imaging.
Main Results:
- HER2- and HER3-targeted PET can accurately diagnose breast cancer.
- This imaging modality helps evaluate the response to targeted therapies.
- PET imaging provides insights into intratumoral and metastatic heterogeneity.
Conclusions:
- HER2- and HER3-targeted PET imaging is crucial for diagnosing breast cancer.
- It serves as an important tool for monitoring treatment response.
- Advanced imaging techniques improve the understanding of breast cancer biology and treatment outcomes.
More Related Videos
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Clinical Applications of Epidermal Stem Cells
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity
Transcription Factors